atrial fibrillation

By Jonah Comstock February 1, 2018
The Apple Heart Study — which began enrollment at the end of November — has now begun data collection, with participants receiving prompts over the weekend to sign informed consent documents and initiate data collection. That document also reveals some new details about how Apple plans to use data collected during the study.  “This study is part of the development of a new investigational device...
By Jonah Comstock November 30, 2017
The Apple Heart Study, an Apple Watch-based ResearchKit study using the heart rate sensor to look at potential arrhythmias, is launching today, the Cupertino tech giant told MobiHealthNews. Apple Chief Operations Officer Jeff Williams announced the study, which is being conducted in collaboration with Stanford University and with assistance from American Well, at Apple’s iOS 8 launch event in...
By Dave Muoio October 11, 2017
Patient, provider atrial fibrillation apps launch. Two new smartphone and tablet apps targeting atrial fibrillation and designed by the European Society of Cardiology (ESC) and the University of Birmingham have launched for free on the iOS App Store and Google Play store. My AF provides patients with information about the condition, treatments, and tips on improving lifestyle, and allows patients...
By Dave Muoio September 12, 2017
Among Apple’s many device and technology reveals today was an announcement that new health managing software would be built into Apple Watches. Starting Sept. 19, fitness-focused heart rate monitoring will be brought to the face of the watch, alongside warning notifications if an elevated heart rate is detected during a period of inactivity.  The consumer electronics giant will be using this...
By Jonah Comstock September 6, 2017
AliveCor, makers of the Kardia Mobile smartphone-connected ECG, announced the results of several major studies of the technology, including one that was published online today in Circulation, the journal of the American Heart Association. The studies show the effectiveness of the technology in discovering atrial fibrillation that might otherwise have gone undetected, as well as its ease of use. "...
By Jonah Comstock July 11, 2017
A team of researchers from Stanford University, working with cardiac monitoring company iRhythm, have created an AI algorithm that, in a small proof-of-concept trial, outperformed board-certified cardiologists at identifying various types of arrhythmias from ECGs. The results have been published to arXiv, an online archive for scientific papers, but have not yet appeared in a peer-reviewed...
By Jonah Comstock May 11, 2017
Cardiogram, a startup working on algorithms to make the Apple Watch’s heart rate data clinically actionable, announced some results today from its mRhythm Study. The data, presented at the Heart Rhythm Society’s 38th Annual Scientific Sessions, shows that the company’s algorithms can detect atrial fibrillation with 97 percent accuracy. “Our results show that common wearable trackers like...
By Jonah Comstock October 20, 2016
Cardiogram, a startup seeking to make the sensor data from the Apple Watch more useful for the average watch user, and, eventually, useful in a clinical context, has raised $2 million in a round led by Andressen Horowitz's new bio fund, led by Vijay Pande. A number of angel investors also contributed: Homebrew (Satya Patel, VP Product of Twitter and Hunter Walk, Director of Product for YouTube),...
By Jonah Comstock April 11, 2016
AliveCor is continuing to build up the clinical evidence for the efficacy of its smartphone-connected Kardia ECG devices. According to a new posting on ClinicalTrials.gov, AliveCor is gearing up to launch a 300-patient randomized trial at Columbia University to test the effect of technology-enabled remote monitoring on atrial fibrillation. "Atrial fibrillation (AF), a condition where the top...
By Jonah Comstock April 11, 2016
Doctors at an emergency room in New Jersey used data from a patient's Fitbit activity tracker -- which they happened to notice on his wrist -- to determine his course of treatment. When the 42-year-old patient showed up in the ER at Our Lady of Lourdes Medical Center in Camden, New Jersey, he had already had a seizure and he had atrial fibrillation. Doctors had to decide whether or not to use an...